Shoulder pain is the inferior most...

Shoulder pain is the inferior most common reason for time taken against work in the United States. In middle-aged adults, the primary cause of shoulder pain is degeneration of the rotator box tendons. This degeneration occurs as a normal part of aging, beginning with beat tendinosis and progressing to partial- or full-thickness tears. In chaste cases, it leads to massive slap tears and osteoarthritis of the glenohumeral joint. Multiple factors play a part in developing cuff degeneration, including tension overload, primary or secondary impingement, impaired repair mechanisms, and overhead activities. Treatment of rotator blow tendinosis includes rest, activity modification, and physical therapy. undivided (controversial) treatment option is corticosteroid injection. Studies demonstrate positive and negative issues with corticosteroid injection; however, not many have used sham injections as a bridle Alvarez and associates performed a randomized controll trial of patients with chronic rotator beat tendinosis to evaluate the efficacy of subacromial injections of betamethasone (Celestone) with lidocaine (Xylocaine) compared with lidocaine alone.

Inclusion criteria for the trial included pain in and around the shoulder or lateral deltoid area and pain performing overhead activity, with the following physical examination findings: pain onward palpation of the cuff and its insertion into the proximal humorous; positive Neer impingement sign (pain when the arm is placed in satiated pronation and flexed against pressure); and decreased or painful range of motion. Participants were randomly assigned to subacromial posterolateral injection of 1 mL (6 mg) of betamethasone with 4 mL of 2 percent lidocaine or 5 mL of 2 percent lidocaine alone (control) The injections were given on the two principal investigators using pre-filled syringes to blind the trial. issue measures included a disease-specific quality-of-life index complet through each participant, standardized shoulder assessments, a Neer impingement sign evaluation, and active range of motion. Participants were evaluated at sum of two units weeks, six weeks, three month and six month after the injection.

Sixty-two patients qualified for the subject of attention and 58 completed it. Patients in the sum of two units groups were similar at baseline with regard to sex age, hand dominance, duration of symptoms, Workplace Safety and Insurance Board status, and subjective and objective measurements. the pair groups showed improvement in their quality-of-life scores during the cogitation There was no statistically significant difference between the clusters in the scores for any of the issues at any time during the studious mood with the exception of active forward elevation at sum of two units weeks (148.8 [+ or -] 175 stations in the betamethasone group compared with 1333 [+ or -] 254 in the command group). This difference was not not away at subsequent evaluations. At six month 13 percent of the betamethasone dispose and 18 percent of the repress group reported a "good to excellent" result

The authors end that subacromial injection of betamethasone with lidocaine for six month was no more effective than lidocaine alone in the treatment of patients with chronic rotator stroke tendinosis unresponsive to nonsteroidal anti-inflammatory mix with drugss and physical therapy. They add that despite the popularity of this intervention, they were unable to document any benefit to subacromial corticosteroid injection in these patients.

KARL E MILLER, MD

Alvarez CM et al. A prospective, double-blind, randomized clinical trial comparing subacromial injection of betamethasone and xylocaine to xylocaine alone in chronic rotator slap tendinosis. Am J Sports M February 2005;33:255-62

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group